Anuma launches private AI with one memory across every leading model
SAN FRANCISCO, April 27, 2026 (GLOBE NEWSWIRE) -- Anuma today opened to…
ElevateBio to Present Nine Abstracts Showcasing Advancements Across its Gene Editing Platform at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting
April 27, 2026 17:00 ET | Source: ElevateBio – Posters detail large…
Dreame will unveil its latest wet dry vacuum innovations in Silicon Valley, building on rapid growth across the world
SAN FRANCISCO, April 25, 2026 /PRNewswire/ -- As part of DREAME NEXT,…
Zendure Debuts SolarFlow Mix Series Across Europe — Three Home Storage Systems, One Platform, Up to 91% Off the Bill
DÜSSELDORF, Germany, April 22, 2026 /PRNewswire/ -- Zendure, a global pioneer of…
Kyverna Presents Registrational Trial Primary Analysis for Miv-cel in Stiff Person Syndrome Demonstrating Statistically Significant, Durable Clinical Benefit Across All Endpoints in an Oral, Late-Breaker Session at AAN Annual Meeting
Single-dose of miv-cel achieved robust and durable improvements in mobility, reversed disability…
Revolution Medicines to Present Updated Phase 1/2 Clinical Data for Daraxonrasib in First Line Metastatic Pancreatic Cancer Across Monotherapy and Combination Cohorts at the 2026 AACR Annual Meeting
REDWOOD CITY, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc.…
VF Corporation enters partnership with Nedap to unlock end-to-end inventory visibility across its global store estate
GROENLO, The Netherlands, April 21, 2026 /PRNewswire/ -- Nedap (AMS:NEDAP), a leader in item-level…
LYKSTAGE Launches Patented Video Platform That Pays Creators and Viewers — Now Live Across Five Countries
MUMBAI, India, April 20, 2026 /PRNewswire/ -- LYKSTAGE, a video-sharing platform owned…
Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026
April 19, 2026 19:45 ET | Source: Sutro Biopharma, Inc. STRO-004 demonstrates…
argenx Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDP
ADAPT OCULUS is the first study to evaluate a targeted treatment for…
